Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia: A Single Centre Experience in Malaysia

BACKGROUND: Hematopoietic stem cell transplantation (HSCT) provides curative therapy in almost 90% of patients with severe aplastic anemia (SAA). Older age, long duration of disease with consequent heavy exposure to transfusion, and active infection at the time of HSCT have a negative influence on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilfred, Gilbert, Ong, Tee Chuan, SH Shahnaz, Syed Abd Kadir, Wah, Ho Kim, Carlo, Edmund Syed, Jameela, Sathar, Mui Tan, Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia-Pacific Blood and Marrow Transplantation Group 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870683/
https://www.ncbi.nlm.nih.gov/pubmed/36710947
http://dx.doi.org/10.31547/bct-2021-018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870683/
https://www.ncbi.nlm.nih.gov/pubmed/36710947
http://dx.doi.org/10.31547/bct-2021-018

Ejemplares similares